mRNA |
linifanib |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
CHM-1 |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.003 |
mRNA |
YK 4-279 |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.004 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.004 |
mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.004 |
mRNA |
hyperforin |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.004 |
mRNA |
lenvatinib |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.004 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.005 |
mRNA |
LRRK2-IN-1 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.005 |
mRNA |
BRD-K97651142 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.005 |